Back
Strategy, Inc. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Sell
37
MSTR
Strategy, Inc.
Last Price:
$184.56
Seasonality Move:
16.83%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$68.84
Seasonality Move:
40.49%
Sell
37
Strategy, Inc. (MSTR)
is a Sell
Is Strategy, Inc. a Buy, Sell or Hold?
-
The current Strategy, Inc. [MSTR] share price is $188.99. The Score for MSTR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
MSTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.83. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MSTR Stock Price Chart
What is Strategy, Inc.'s stock price today?
-
The Strategy, Inc. share price today is $188.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSTR is experiencing slight selling pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $68.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
MSTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -19.41 | Sell |
| Relative Strength Index (14 RSI): | 40.76 | Sell |
| Chaikin Money Flow: | -446390 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (173.43 - 226.85) | Sell |
| Bollinger Bands (100): | (233.84 - 377.18) | Sell |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.39 | Buy |
| Relative Strength Index (14 RSI): | 76.07 | Buy |
| Chaikin Money Flow: | 2789125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.57 - 58.79) | Buy |
| Bollinger Bands (100): | (20.11 - 45.67) | Buy |
MSTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 182 | Buy |
| 20-day SMA: | 189.17 | Sell |
| 50-day SMA: | 251.93 | Sell |
| 200-day SMA: | 328.79 | Sell |
| 8-day EMA: | 184.03 | Buy |
| 20-day EMA: | 196.56 | Sell |
| 50-day EMA: | 239.17 | Sell |
| 200-day EMA: | 299.4 | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.94 | Buy |
| 20-day SMA: | 50.39 | Buy |
| 50-day SMA: | 42.93 | Buy |
| 200-day SMA: | 24.04 | Buy |
| 8-day EMA: | 62.02 | Buy |
| 20-day EMA: | 53.73 | Buy |
| 50-day EMA: | 44.48 | Buy |
| 200-day EMA: | 29.61 | Buy |
Strategy, Inc. Earnings Growth & MSTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $5.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $65.78 per share, and an increase next year of $14.78 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
Strategy, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||